Syneron Medical Ltd. (ELOS) announced that is has signed a definitive agreement to acquire substantially all the assets of TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an active transdermal drug delivery technology.
As per terms of the agreement, Syneron will acquire substantially all the assets of TransPharma, including its patent portfolio, for approximately $3.6 million in cash. The acquisition is subject to customary closing conditions.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.